Cholesterol drug shows promise in ovarian cancer trial
Disease control
Completed
This pilot study tested whether adding simvastatin, a cholesterol-lowering drug, to standard chemotherapy could slow cancer growth in 18 women with recurrent, platinum-sensitive ovarian cancer. Participants received simvastatin alongside carboplatin and liposomal doxorubicin. The…
Phase: EARLY_PHASE1 • Sponsor: Marc Goodman • Aim: Disease control
Last updated May 26, 2026 12:01 UTC